Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis

OBJECTIVE: Patients with inflammatory arthritis (IA) associated with immune checkpoint inhibitor (ICI) treatment for cancer are typically seronegative for anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid factor, but little is known about the presence of other autoantibodies in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappelli, Laura C, Bingham, Clifton O, Forde, Patrick M, Anagnostou, Valsamo, Brahmer, Julie, Lipson, Evan J, Mammen, Jennifer, Schollenberger, Megan, Shah, Ami A, Darrah, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Inflammatory Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472204/
https://www.ncbi.nlm.nih.gov/pubmed/36096522
http://dx.doi.org/10.1136/rmdopen-2022-002511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472204/
https://www.ncbi.nlm.nih.gov/pubmed/36096522
http://dx.doi.org/10.1136/rmdopen-2022-002511

Ejemplares similares